Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 41Leukemia 34Lymphoma 22Myelodysplastic Syndromes 16Hodgkin Disease 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Acute 9Recurrence 8Myeloproliferative Disorders 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Chronic-Phase 7Anemia, Aplastic 7Waldenstrom Macroglobulinemia 6Lymphoma, T-Cell, Peripheral 6Congenital Abnormalities 6Burkitt Lymphoma 6Sezary Syndrome 5Primary Myelofibrosis 5Neoplasms, Plasma Cell 5Mycosis Fungoides 5Lymphoma, Large-Cell, Immunoblastic 5Graft vs Host Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, T-Cell, Cutaneous 4

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Clofarabine 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metabolic Diseases × Alemtuzumab × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡